MENU
PEPG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
PepGen (PEPG) Ownership - Who owns PepGen?
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases... Show more
Profile
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 781 797-0979
Employees
64
Web
https://www.pepgen.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
40.02M
P/E Ratio
N/A
Total Cash
74.65M
Projected Growth
N/A
Total Debt
17.86M
Revenue
N/A
Risk (Beta)
1.16
Dividend Yield
N/A
Total Cash/Share
2.28
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PEPG
Capitalization
40M
P/E Ratio
N/A
Risk (Beta)
1.16
Dividend Yield
N/A
Total Cash
74.7M
Total Cash/Share
2.28
Total Debt
17.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
71.2M
P/B Ratio
0.56
Cash Flow
N/A
Earnings
-2.96
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
4.74
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-97.54M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-65.54
Shares Held By Institutions
166M
Shares Outstanding - Current
32.8M
Total Liabilities
31.1M
Total Volume MTD
N/A
Value
1
Gain YTD
-67.810
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PEPG showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 781 797-0979
Employees
64
Web
https://www.pepgen.com